After grabbing 3.1 million shares, the institutional investor is now in possession of 3.1 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 4.18% having worth around $29.08 million. Moreover, BlackRock Fund Advisors increased its share by 2.57 million to have a control over 3.08 million shares. And VHCP Management LLC raised its holdings to 2.77 million shares by acquiring 2.77 million shares or 3.73% of the stake.

Vaxart Inc. (VXRT) concluded trading on 08/26/20 at a closing price of $6.71, with 9.42 million shares of worth about $63.23 million changed hands on the day. Weekly performance of the stock remained negative as price took a plunge of -27.14% during that period and on Wednesday the price saw a loss of about -3.45%. Currently the company’s common shares owned by public are about 109.20M shares, out of which, 108.18M shares are available for trading.

A deeper look into what the analysts at Wall Street are thinking about the price target of this stock provides us with the following: 3 analysts are covering the VXRT stock and their offered price forecasts bring an average price target of $19.67. Over the next 12 months, analysts forecasted that the stock’s price could jump as high as $22.00 and could fall to a lowest price of $17.00. Analysts also issued an outlook of 2.00 for the Vaxart Inc. stock for next 12 months. However, touching the estimated high of $22.00 would mean a gain of 69.5% for the stock.

According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 65 times over the past 12 months. They bought 28,047,893 shares in 28 of the transactions. In 37 selling transactions, insiders dumped 40,622,053 shares.

iShares Russell 2000 ETF, Vanguard Extended Market Index Fu, and iShares Russell 2000 Growth ETF are the top 3 mutual funds which are holding stakes in Vaxart Inc. iShares Russell 2000 ETF is currently holding 0.91 million shares of worth totaling $8.58 million. The company recently came selling 42840.0 shares which brought its stake up to 1.23% of the company’s outstanding shares. Vanguard Extended Market Index Fu bought 0.27 million shares, after which its hold over company’s outstanding shares expand to 1.20%, leaving 0.89 million shares with the mutual fund that have a worth of about $8.32 million. iShares Russell 2000 Growth ETF, after selling 0.35 million shares, have now control over 0.47% of the stake in the company. It holds 3432.0 shares of worth $3.27 million.

Vaxart Inc. (NASDAQ: VXRT) started trading at $6.917, below -$0.03 from concluding price of the previous day. However, the stock finished the trading on the day at a closing price of $6.71, or with a loss of -3.45%. Stock saw a price change of -27.14% in past 5 days and over the past one month there was a price change of -40.04%. Year-to-date (YTD), VXRT shares are showing a performance of 1814.41% which increased to 879.71% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.25 but also hit the highest price of $17.49 during that period. While comparing its average daily trading volume of 25.98 million shares, we see that about 9.42 million changed hands on the day. The stock is currently trading -26.76% below its 20-day simple moving average (SMA20), while that difference is down -26.37% for SMA50 and it goes to 97.97% higher than SMA200.

Citadel Advisors LLC acquired 3.1 million shares of Vaxart Inc. having value of about $29.08 million. Vaxart Inc. (NASDAQ: VXRT) currently have 109.20M outstanding shares and institutions hold larger chunk of about 21.80% of that. Holding of mutual funds in the company is about 23.19% while other institutional holders and individual stake holders have control over 5.57% and 1.80% of the stake respectively.

The stock has a current market capitalization of $785.34M and its 3Y-monthly beta is at 0.19. It has posted earnings per share of -$0.60 in the same period. It has Quick Ratio of 4.00 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for VXRT, volatility over the week remained 10.69% while standing at 12.10% over the month.

Analysts are in expectations that Vaxart Inc. (VXRT) stock would likely to be making an EPS of -$0.09 in the current quarter, while forecast for next quarter ESPS is -$0.09 and it is -$0.3 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.11 which is -$0.06 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.32 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 70.20% while it is estimated to increase by 14.30% in next year.

Analysts at 3 brokerage firms have issued recommendations for the Vaxart Inc. (VXRT)’s stock and average of those rates the stock at a “Moderate Buy” and assign it a score of 2.00. Out of those 3 Wall Street analysts, 3 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.

Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on August 12, 2020 offering a Buy rating for the stock and assigned a target price range of between $7 and $17 to it. Coverage by B. Riley FBR stated Vaxart Inc. (VXRT) stock as a Buy in their note to investors on July 13, 2020, suggesting a price target of $22 for the stock.